AstraZeneca and CSPC Pharmaceutical have signed a research deal worth up to USD 5.3 billion to co-develop oral therapies for chronic and immunological diseases. CSPC will lead discovery in China using ...

Both China and the EU face heavy trade pressure from the White House. Trump’s tariffs on China remain at 30% even after the ...

Before filing for an IPO in the US, Ximalaya raised close to RMB 10 billion (USD 1.4 billion) over 12 funding rounds. Its cap ...

While robots grab the spotlight, component makers like ZeroErr are quietly benefiting from the surge in demand.

Laifen is sinking serious money into shavers, wagering that innovation will help it trump incumbents like Philips and Braun.

In China, Manus has made waves by claiming it has the world’s “first general AI agent” that can do everything from screening ...

Digit aims to commercialize humanoid robotics that reflect the potential of artificial general intelligence (AGI). Its core ...

As a wave of cost-consciousness sweeps across China, businesses offering quality at a discount have seen earnings surge while ...

Nooka turns books into conversational podcasts, creating a new form of content where storytelling starts with dialogue.

Atome, a buy now, pay later (BNPL) platform under Advance Intelligence Group, has secured a USD 75 million asset-backed ...

The CEO argues that the future of robotics depends on developing models that can adapt to dynamic, unstructured environments.

Once awash in hype and capital, players like Barley are returning to medical fundamentals to rebuild trust and value.